BNP Paribas Financial Markets’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$170K Buy
30,996
+25,426
+456% +$139K ﹤0.01% 3032
2025
Q1
$35K Sell
5,570
-2,116
-28% -$13.3K ﹤0.01% 3564
2024
Q4
$31.7K Sell
7,686
-4,244
-36% -$17.5K ﹤0.01% 3739
2024
Q3
$39.8K Buy
11,930
+6,764
+131% +$22.6K ﹤0.01% 2931
2024
Q2
$15.4K Sell
5,166
-15,411
-75% -$45.9K ﹤0.01% 2995
2024
Q1
$71K Sell
20,577
-111,632
-84% -$385K ﹤0.01% 2848
2023
Q4
$177K Buy
132,209
+122,543
+1,268% +$164K ﹤0.01% 2551
2023
Q3
$21.1K Sell
9,666
-1,183
-11% -$2.58K ﹤0.01% 2880
2023
Q2
$25.9K Buy
+10,849
New +$25.9K ﹤0.01% 2945